Acelrx Pharmaceuticals Inc
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Acelrx Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Acelrx Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Dicerna Pharmaceuticals (DRNA) CEO Doug Fambrough on Q1 2021 Results - Earnings Call Transcript via Seeking Alpha
Ionis Pharmaceuticals upgraded to neutral from sell at UBS via MarketWatch
Ionis Pharmaceuticals Drops on Wide Quarterly Loss via Yahoo Finance
Acelrx Pharmaceuticals Inc Performance
Active Alerts for IEX:ACRX
You don't have any alerts set for IEX:ACRX.
About Acelrx Pharmaceuticals Inc
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
Real-time ACRX to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.